Facilitated analysis of data on drug regimen compliance

Statistics in Medicine

Volumn 16, Issue 14, 1997, Pages 1653-1664

  De Klerk, Erik ^a   Van Der Linden, Sjef ^a   Van Der Heijde, Desiree ^a   Urquhart, John ^b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL; DATA ANALYSIS; DRUG DOSE; DRUG MECHANISM; PATIENT MONITORING;

EID: 0030748066     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0258(19970730)16:14<1653::aid-sim591>3.0.co;2-#     Document Type: Article

References (48)

1. Kass, M. A., Gordon, M., Morley, R. E., Meltzer, D. W. and Goldberg, J. J. 'Compliance with topical timolol treatment', American Journal of Ophthalmology, 103, 188-193 (1987).
2. Cramer, J. A., Mattson, R. H., Prevey, M. L., Scheyer, R. D. and Ouellette, V. L. 'How often is medication taken as prescribed? A novel assessment technique', Journal of the American Medical Association, 261, 3273-3277 (1989).
3. Averbuch, M., Weintraub, M. and Pollack, D. J. 'Compliance assessment in clinical trials: the MEMS device', Journal of Clinical Research in Pharmaco-epidemiology, 4, 199-204 (1990).
4. Eisen, S. A., Woodward, R. S., Miller, D., Spitznagel, E. and Windham, C. A. 'The art of medication compliance on the control of hypertension', Journal of General Internal Medicine, 2, 298-305 (1987).
5. Kass, M. A., Zimmerman, T., Yablonski, M. and Becker, B. 'Compliance to pilocarpine therapy', Investigations in Ophthalmology, (ARVO abstracts supplement), 108, abstract 2 (1977).
6. Urquhart, J. 'Patient compliance with prescribed drug regimens: overview of the past 30 years of research', in Nimmo, W. S. and Tucker, C. T. (eds), Clinical Measurement in Drug Evaluation, Wiley, Chichester, 1995, pp. 213-227.
7. Feinstein, A. R. 'On white-coat effects and the electronic monitoring of compliance', Archives of Internal Medicine, 150, 1377-1378 (1990).
8. Bond, W. S. and Hussar, D. A. 'Detection methods and strategies for improving medication compliance', American Journal of Hospital Pharmacy, 48, 1978-1988 (1991).
9. Kruse, W. 'Patient compliance with drug treatment - new perspectives on an old problem', Clinical Investigations, 70, 163-166 (1992).
10. Cramer, J. A. 'Microelectronic systems for monitoring and enhancing patient compliance with medication regimens', Drugs, 49, 321-327 (1995).
11. Potter, L. S. 'Oral contraceptive compliance and its role in the effectiveness of the method', in Cramer, J. A. and Spilker, B. (eds), Compliance in Medical Practice and Clinical Trials, Raven Press, New York, 1991, pp. 195-207.
12. Tashkin, D. P., Rand, C., Nides, M., Simmons, M., Wise, R., Coulson, A. H., Li, V. and Gong, H. Jr. 'A nebulizer chronolog to monitor compliance with inhaler use', American Journal of Medicine, 91, (suppl 4A), 33S-36S (1991).
13. Mawhinney, H., Spector, S. L., Kinsman, R. A., Siegel, S. C., Rachelefsky, G. S., Katz, R. M. and Rohr, A. S. 'Compliance in clinical trials of two nonbronchodilator, antiasthma medications', Annals of Allergy, 66, 294-299 (1991).
14. Pullar, T. and Feely, M. 'Problems of compliance with drug treatment: new solutions?', Pharmaceutical Journal, 245, 213-215 (1990).
15. Vander Stichele, R. 'Measurement of patient compliance and the interpretation of randomized clinical trials', European Journal for Clinical Pharmacology, 41, 27-35 (1991).
16. Rudd, P. 'Compliance with antihypertensive therapy: a shifting paradigm', Cardiology in Review, 2, 230-240 (1994).
17. Waterhouse, D. M., Calzone, K. A., Mele, C. and Brenner, D. E. 'Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring', Journal of Clinical Oncology, 11, 1189-1197 (1993).
18. Matsui, D., Hermann, C., Braudo, M., Ito, S., Olivieri, N. and Koren, G. 'Clinical use of the Medication Event Monitoring System: a new window into pediatric compliance', Clinical Pharmacology and Therapeutics, 52, 102-103 (1992).
19. Guerrero, D., Rudd, P., Bryant-Kosling, C. and Middleton, B. F. 'Antihypertensive medication-taking. Investigation of a simple regimen', American Journal of Hypertension, 6, 586-592 (1993).
20. Matsui, M., Hermann, C., Klein, J., Berkowitch, M., Olivieri, N. and Koren, G. 'Critical comparison of novel and existing methods of compliance assessment during a clinical trial of an oral iron chelator', Journal of Clinical Pharmacology, 34, 944-949 (1994).
21. Kalvik, A., Kwok, M., Tseng, A., Currie, N., Busto, U. E. and Naranjo, C. A. 'Variations in medication management systems (MEMS) performance', Clinical Pharmacology and Therapeutics, 55, 157 (1994).
22. Cramer, J. A., Scheyer, R. D. and Mattson, R. H. 'Compliance declines between clinic visits', Archives of Internal Medicine, 150, 1509-1510 (1990).
23. Pullar, T., Kumar, S., Tindall, H. and Feely, M. 'Time to stop counting the tablets?', Clinical Pharmacology and Therapeutics, 46, 163-168 (1989).
24. Rubio, A., Cox, C. and Weintraub, M. 'Prediction of diltiazem plasma concentration curves from limited measurements using compliance data', Clinical Pharmacokinetics, 22, 238-246 (1992).
25. Rubin, D. 'Comment: dose-response estimands', Journal of the American Statistical Association, 86(413), 22-24 (1991).
26. Urquhart, J. 'Role of patient compliance in clinical pharmacokinetics: review of recent research', Clinical Pharmacokinetics, 27, 202-215 (1994).
27. Efron, B. and Feldman, D. 'Rejoinder', Journal of the American Statistical Association, 86(413), 25-26, (1991).
28. Efron, B. and Feldman, D. 'Compliance as an explanatory variable in clinical trials', Journal of the American Statistical Association, 86(413), 9-17 (1991).
29. Katz, R. 'Regulatory view: use of subgroup data for determination of efficacy', in Cramer, J. A. and Spilker, B. (eds), Compliance in Medical Practice and Clinical Trials, Raven Press, New York, 1991, pp. 251-264.
30. The Lipid Research Clinics Coronary Primary Prevention Trial results: '(I) Reduction in incidence of coronary heart disease; (II) The relationship of reduction in incidence of coronary heart disease to cholesterol lowering', Journal of the American Medical Association, 251, 351-374 (1984).
31. QUESTRAN (cholestyramine). Physicians' Desk Reference, 49th edn. Medical Economics Press, Oradell, NJ, 1995, pp. 736-738.
32. Guillebaud, J. 'Any questions', British Medical Journal, 307, 617 (1993).
33. Lasagna, L. and Hutt, P. B. 'Health care, research, and regulatory impact of noncompliance', in Cramer, J. A. and Spilker, B. (eds), Compliance in Medical Practice and Clinical Trials, Raven Press, New York, 1991, pp. 393-403.
34. Sheiner, L. B. and Rubin, D. B. 'Intention to treat analysis and the goals of clinical trials', Clinical Pharmacology and Therapeutics, 57, 6-15 (1995).
35. Urquhart, J. 'Patient compliance as an explanatory variable in four selected cardiovascular studies', in Cramer, J. A. and Spilker, B. (eds), Compliance in Medical Practice and Clinical Trials, Raven Press, New York, 1991, pp. 301-322.
36. Peck, C. C., Barr, W. H., Benet, L. Z., Collins, K, Desjardins, R. E., Furst, D. E., Harter, J. G., Levy, G, Ludden, T., Rodman, J. H., Sanathanan, L., Schentag, J. J., Shah, V. P., Sheiner, L. B., Skelly, J. P., Stanski, D. R., Temple, R. J., Viswanathan, C. T., Weissinger, J. and Yacobi, A. 'Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug development', Clinical Pharmacology and Therapeutics, 51, 465-473 (1992).
37. Peck, C. C. 'Clinical new drug development: "How golden are the eggs?"', Inaugural professional lecture, University of Leiden, the Netherlands, 29 March 1994. Privately printed.
38. Urquhart, J. 'Correlates of variable patient compliance in drug trials: relevance in the new health care environment', in. Testa, B. and Meyer, U. A. (eds), Advances in Drug Research, Academic Press, London, 1995, pp. 237-257.
39. Johnson, B. F. and Whelton, A. 'A study design for comparing the effects of missing daily doses of antihypertensive drugs', American Journal of Therapeutics, 1, 260-267 (1994).
40. de Klerk, E. and van der Linden, S. 'Compliance monitoring of NSAID drug-therapy in ankylosing spondylitis, experiences with an electronic monitoring device', British Journal of Rheumatology, 35, 60-65 (1996).
41. van der Linden, S., Valkenburg, H. A. and Cats, A. 'Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria', Arthritis and Rheumatism, 27, 361-368 (1984).
42. Norell, S. E., Granstrom, P. A. and Wassen, R. 'A medication monitor and fluorescein technique designed to study medication behaviour', Acta Ophthalmology, 58, 459 (1980).
43. Petri, H. and Urquhart, J. 'Patient compliance with beta-blocker medication in general practice', Pharmacoepidemiology and Drug Safety, 3, 251-256 (1994).
44. Prazosin hydrochloride. Physicians' Desk Reference, 49th edn, Medical Economics Press, Oradell, NJ, 1995, pp. 1873-1874.
45. Flecainide acetate. Physicians' Desk Reference, 49th edn, Medical Economics Press, Oradell, NJ, 1995, pp. 1387-1390.
46. McCann, M. F. and Potter, L. S. 'Progestin-only oral contraception: a comprehensive review', Contraception, 50, (suppl 1), S9-S195 (1994).
47. Knipschild, P., Leffers, P. and Feinstein, A. R. 'The qualification period', Journal of Clinical Epidemiology, 44, 461-464 (1991).
48. Levy, G. 'A pharmacokinetic perspective on medicament noncompliance', Clinical Pharmacology and Therapeutics, 54, 242-244 (1993).